Why the study?
Despite increasing fragility fractures, multidisciplinary shared care for hip fractures is rare in low- and middle-income countries.
Does the introduction of multidisciplinary care pathways improve quality of life and reduce healthcare costs in patients with hip fracture in low- and middle-income countries?
Does the introduction of multidisciplinary care pathways improve quality of life and reduce healthcare costs in patients with hip fracture in low- and middle-income countries?
The HIPCARE trial aims to evaluate whether multidisciplinary care pathways can improve quality of life and reduce costs for hip fracture patients in low- and middle-income countries.
Multidisciplinary hip fracture care untested in LMICs; HIPCARE leaves open whether UK benefits extend to these settings.
In the UK, multidisciplinary teamwork for patients with hip fracture has been shown to reduce mortality and improves health-related quality of life for patients, while also reducing hospital bed days and associated healthcare costs. However, despite rapidly increasing numbers of fragility fractures, multidisciplinary shared care is rare in low- and middle-income countries around the world. The HIPCARE trial will test the introduction of multidisciplinary care pathways in five low- and middle-income countries in South and Southeast Asia, with the aim to improve patients' quality of life and reduce healthcare costs.
No takes yet. Share an insight, caveat, or question.
Tabu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: